Concepedia
Statistics
Publications
15
Citations
867
H-Index
Active since
2008
Affiliations
Brigham and Women's Hospital(Current)
Harvard University
Broad Institute
Dana-Farber Cancer Institute
University of Pittsburgh Medical Center
Amy Ko is an author at Brigham and Women's Hospital specializing in medicine, cancer therapeutics, and radiation oncology.
Top concepts
MedicineOncologyPharmacologyCancer TherapyMolecular OncologyRadiation OncologyBiologyUrologyGeneticsPathology
Publications per year
2008–2019
Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation
Shannon Elf, Nouran S. Abdelfattah, Edwin Chen et al. · Cancer Discovery · 2016 · 272 citations · Full text
Distinct effects of concomitant Jak2V617F expression and Tet2 loss in mice promote disease progression in myeloproliferative neoplasms
Edwin Chen, Rebekka K. Schneider, Lawrence J. Breyfogle et al. · Blood · 2014 · 97 citations · Full text
Defining the requirements for the pathogenic interaction between mutant calreticulin and MPL in MPN
Shannon Elf, Nouran S. Abdelfattah, April J. Baral et al. · Blood · 2017 · 88 citations · Full text
Incidence of Varicose Veins, Chronic Venous Insufficiency, and Progression of the Disease in the Bonn Vein Study II
Eberhard Rabe, Felizitas Pannier, Amy Ko et al. · Journal of Vascular Surgery · 2010 · 55 citations
Phase II trial of FOLFOX plus bevacizumab in advanced, progressive neuroendocrine tumors
Alan P. Venook, Amy Ko, Margaret A. Tempero et al. · Journal of Clinical Oncology · 2008 · 52 citations
Progressive Neuroendocrine Tumors, Pathology, Pharmacotherapy +17
1–5 of 15